IN2013MU00646A - - Google Patents
Download PDFInfo
- Publication number
- IN2013MU00646A IN2013MU00646A IN646MU2013A IN2013MU00646A IN 2013MU00646 A IN2013MU00646 A IN 2013MU00646A IN 646MU2013 A IN646MU2013 A IN 646MU2013A IN 2013MU00646 A IN2013MU00646 A IN 2013MU00646A
- Authority
- IN
- India
- Prior art keywords
- preparation
- present
- crystalline form
- provides novel
- endoxifen
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
- C07C217/02—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C217/04—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
- C07C217/06—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one etherified hydroxy group and one amino group bound to the carbon skeleton, which is not further substituted
- C07C217/14—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one etherified hydroxy group and one amino group bound to the carbon skeleton, which is not further substituted the oxygen atom of the etherified hydroxy group being further bound to a carbon atom of a six-membered aromatic ring
- C07C217/18—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one etherified hydroxy group and one amino group bound to the carbon skeleton, which is not further substituted the oxygen atom of the etherified hydroxy group being further bound to a carbon atom of a six-membered aromatic ring the six-membered aromatic ring or condensed ring system containing that ring being further substituted
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/IN2014/000136 WO2014141292A2 (en) | 2013-03-04 | 2014-03-03 | Endoxifen citrate polymorph and process for preparing the same |
| IN646MU2013 IN2013MU00646A (instruction) | 2013-03-04 | 2014-03-03 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN646MU2013 IN2013MU00646A (instruction) | 2013-03-04 | 2014-03-03 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IN2013MU00646A true IN2013MU00646A (instruction) | 2015-06-26 |
Family
ID=51538243
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IN646MU2013 IN2013MU00646A (instruction) | 2013-03-04 | 2014-03-03 |
Country Status (2)
| Country | Link |
|---|---|
| IN (1) | IN2013MU00646A (instruction) |
| WO (1) | WO2014141292A2 (instruction) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2016202161A1 (zh) | 2015-06-16 | 2016-12-22 | 江苏恒瑞医药股份有限公司 | 哌啶类衍生物、其制备方法及其在医药上的应用 |
| MX2018007844A (es) | 2015-12-22 | 2019-01-21 | Jiangsu Hengrui Medicine Co | Derivado de benzopiperidina, metodo de preparacion del mismo y su uso medico del mismo. |
| AU2018329202B2 (en) | 2017-09-11 | 2022-10-27 | Atossa Therapeutics, Inc. | Methods for making and using endoxifen |
| CA3082276C (en) | 2017-11-14 | 2022-08-16 | Anlin Pharmaceuticals, Llc | Heterocyclic compounds and their application in medicine |
| US12201591B2 (en) | 2019-07-03 | 2025-01-21 | Atossa Therapeutics, Inc. | Sustained release compositions of endoxifen |
| TWI882060B (zh) | 2020-01-10 | 2025-05-01 | 大陸商江蘇恆瑞醫藥股份有限公司 | 三環四氫異喹啉類衍生物、其製備方法及其在醫藥上的應用 |
| CA3185993A1 (en) | 2020-04-10 | 2021-10-14 | Jina Pharmaceuticals, Inc. | Endoxifen for the treatment of bipolar i disorder |
| DK4132495T3 (da) * | 2020-04-10 | 2025-07-21 | Jina Pharmaceuticals Inc | Endoxifen til behandling af bipolar i-lidelse |
| MX2022012519A (es) * | 2020-04-10 | 2023-01-16 | Jina Pharmaceuticals Inc | Endoxifeno para el tratamiento del trastorno bipolar i. |
| JP2024525643A (ja) | 2021-07-09 | 2024-07-12 | 江▲蘇▼恒瑞医▲薬▼股▲フン▼有限公司 | 三環式テトラヒドロイソキノリン系誘導体の塩の形態 |
| TW202340135A (zh) | 2022-01-12 | 2023-10-16 | 美商阿托薩醫療公司 | （ｚ）—因多昔芬之組合物及其富集方法 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW593256B (en) * | 1999-11-16 | 2004-06-21 | Hormos Medical Oy Ltd | Triphenylalkene derivatives and their use as selective estrogen receptor modulators |
| US20090291134A1 (en) * | 2006-11-21 | 2009-11-26 | Jina Pharmaceuticals, Inc. | Endoxifen methods and compositions in the treatment of psychiatric and neurodegenerative diseases |
| WO2009120999A2 (en) * | 2008-03-28 | 2009-10-01 | Olema Pharmaceuticals, Inc. | Use of an endoxifen prodrug for treatment of breast cancer |
| KR101308258B1 (ko) * | 2010-10-15 | 2013-09-13 | 씨제이제일제당 (주) | 엔독시펜의 신규한 제조 방법 |
-
2014
- 2014-03-03 IN IN646MU2013 patent/IN2013MU00646A/en unknown
- 2014-03-03 WO PCT/IN2014/000136 patent/WO2014141292A2/en active Application Filing
Also Published As
| Publication number | Publication date |
|---|---|
| WO2014141292A2 (en) | 2014-09-18 |
| WO2014141292A3 (en) | 2014-12-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IN2013MU00646A (instruction) | ||
| IN2014CH00247A (instruction) | ||
| MX370649B (es) | Proceso para la preparacion de teneligliptina. | |
| IN2013MU00848A (instruction) | ||
| IL249872A0 (en) | Amorphous form of eliglostat hemetrate, preparations containing it and methods for its preparation | |
| IN2014MU00455A (instruction) | ||
| IL245474A0 (en) | Process for the preparation of 5-fluoro-1h-pyrazoles | |
| IL245476B (en) | Process for the preparation of 5-fluoro-1h-pyrazoles | |
| IN2013MU03070A (instruction) | ||
| MA40447A (fr) | Composition pharmaceutique orale d'isotrétinoïne | |
| MA40312A (fr) | Composition pharmaceutique orale d'isotrétinoïne | |
| IN2013MU01113A (instruction) | ||
| PL2967095T3 (pl) | Sposób wytwarzania serów o zmienionej strukturze | |
| EP3016935A4 (en) | Process for the preparation of intermediate of dolutegravir | |
| PL2964607T3 (pl) | Sposób wytwarzania halogeno-n,n-dimetylobenzyloamin | |
| IL229326A (en) | Process for making n-iodine-affluent | |
| WO2014170909A3 (en) | Process for pomalidomide | |
| IN2013MU02528A (instruction) | ||
| MX2015011881A (es) | Proceso para la preparacion de 3,7-dimetilnonan-1-ol. | |
| IN2013MU03768A (instruction) | ||
| MX382969B (es) | Método para producir halocetonas. | |
| IN2014CH01391A (instruction) | ||
| IN2013MU01501A (instruction) | ||
| IN2013MU01524A (instruction) | ||
| IN2013CH05395A (instruction) |